Simon M. Helfgott

3.3k total citations
46 papers, 1.5k citations indexed

About

Simon M. Helfgott is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Simon M. Helfgott has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 11 papers in Immunology and 8 papers in Genetics. Recurrent topics in Simon M. Helfgott's work include Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Simon M. Helfgott is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Simon M. Helfgott collaborates with scholars based in United States, United Kingdom and Canada. Simon M. Helfgott's co-authors include Michael E. Weinblatt, Jonathan S. Coblyn, Raphael I. Kieval, Derrick J. Todd, David E. Trentham, Agnes L. Maier, Elizabeth W. Karlson, Martin Kriegel, Eben I. Lichtman and Vibeke Strand and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Simon M. Helfgott

46 papers receiving 1.4k citations

Peers

Countries citing papers authored by Simon M. Helfgott

Since Specialization

Citations

This map shows the geographic impact of Simon M. Helfgott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon M. Helfgott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon M. Helfgott more than expected).

Fields of papers citing papers by Simon M. Helfgott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon M. Helfgott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon M. Helfgott. The network helps show where Simon M. Helfgott may publish in the future.

Co-authorship network of co-authors of Simon M. Helfgott

This figure shows the co-authorship network connecting the top 25 collaborators of Simon M. Helfgott. A scholar is included among the top collaborators of Simon M. Helfgott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon M. Helfgott. Simon M. Helfgott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real‐World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First‐Line Tumor Necrosis Factor Inhibitor Therapy in the United States 2024 ·ACR Open Rheumatology ·(unknown), (unknown), Simon M. Helfgott, K. Huston, Jasvinder A. Singh, Patrick Zueger, (unknown), Pankaj Patel, (unknown)	1
2	AB1824-HPR MULTIPLE TNFI TREATMENT CYCLES AND THE FAILURE OF TRIAL-AND-ERROR CARE FOR PATIENTS WITH RHEUMATOID ARTHRITIS 2023 ·Annals of the Rheumatic Diseases ·Simon M. Helfgott, Claire Adams, (unknown), K. Huston, Scott Milligan, Jasvinder A. Singh, (unknown), (unknown)	1
3	Generalized pustular psoriasis‐like widespread eruption following COVID ‐19 infection in a patient with spondyloarthropathy on adalimumab 2023 ·Experimental Dermatology ·Kanika Kamal, (unknown), (unknown), Simon M. Helfgott, Alvaro C. Laga, Vinod E. Nambudiri	1
4	Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID‐19 Pandemic 2020 ·Arthritis & Rheumatology ·Fotios Koumpouras, Simon M. Helfgott	24
5	Prevalence and predictors for sustained remission in rheumatoid arthritis 2019 ·PLoS ONE ·Yoon‐Kyoung Sung, Kazuki Yoshida, Femke H. M. Prince, Michelle Frits, Soo‐Kyung Cho, Jung‐Yoon Choe, (unknown), Jisoo Lee, Shin‐Seok Lee, Dae‐Hyun Yoo, Simon M. Helfgott, Nancy A. Shadick, Michael E. Weinblatt, Daniel H. Solomon, Sang‐Cheol Bae	13
6	Mixed-effects association of single cells identifies an expanded effector CD4 ⁺ T cell subset in rheumatoid arthritis 2018 ·Science Translational Medicine ·Chamith Y. Fonseka, Deepak A. Rao, Nikola C. Teslovich, Ilya Korsunsky, Susan Hannes, Kamil Slowikowski, Michael F. Gurish, Laura T. Donlin, Eddie A. James, Michael E. Weinblatt, Elena Massarotti, Jonathan S. Coblyn, Simon M. Helfgott, Derrick J. Todd, Vivian P. Bykerk, Elizabeth W. Karlson, Joerg Ermann, Yvonne Lee, Michael B. Brenner, Soumya Raychaudhuri	99
7	Analysis of pulmonary features and treatment approaches in the COPA syndrome 2018 ·ERJ Open Research ·Jessica Tsui, Oscar Estrada, (unknown), Kristin M. Wang, Christopher S. Law, Brett M. Elicker, Kirk D. Jones, Sharon Dell, Gunnar Guðmundsson, Sif Hansdóttir, Simon M. Helfgott, Stefano Volpi, Marco Gattorno, Michael Waterfield, Alice Chan, Sharon A. Chung, Brett Ley, Anthony K. Shum	64
8	Emerging therapies for systemic lupus erythematosus — Focus on targeting interferon-alpha 2012 ·Clinical Immunology ·Eben I. Lichtman, Simon M. Helfgott, Martin Kriegel	67
9	Use of the T-SPOT.TB Assay to Detect Latent Tuberculosis Infection Among Rheumatic Disease Patients on Immunosuppressive Therapy 2009 ·The Journal of Rheumatology ·Samuel M. Behar, Daniel S. Shin, Agnes L. Maier, Jonathan Coblyn, Simon M. Helfgott, Michael E. Weinblatt	32
10	The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study 2009 ·Arthritis Research & Therapy ·Yvonne Lee, Lori B. Chibnik, Bing Lü, Ajay D. Wasan, Robert R. Edwards, Anne H. Fossel, Simon M. Helfgott, Daniel H. Solomon, Daniel J. Clauw, Elizabeth W. Karlson	112
11	A Joint Venture 2008 ·New England Journal of Medicine ·(unknown), (unknown), Daniel J. DeAngelo, Simon M. Helfgott	1
12	Leflunomide-associated weight loss in rheumatoid arthritis 2001 ·Arthritis & Rheumatism ·Jonathan S. Coblyn, Nancy A. Shadick, Simon M. Helfgott	28
13	Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment. 2000 ·PubMed ·Daniel H. Solomon, Ellis R. Levin, Simon M. Helfgott	26
14	Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis 1999 ·Arthritis & Rheumatism ·Michael E. Weinblatt, Joel M. Kremer, Jonathan S. Coblyn, Agnes L. Maier, Simon M. Helfgott, (unknown), (unknown), (unknown), Vibeke Strand	191
15	Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate 1996 ·Arthritis & Rheumatism ·Simon M. Helfgott, Raphael I. Kieval	51
16	Treatment of stiff‐man syndrome with intravenous immune globulin 1994 ·Arthritis & Rheumatism ·Elizabeth W. Karlson, Lewis Sudarsky, Eric Ruderman, (unknown), Mary P. Scott, Simon M. Helfgott	35
17	Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss 1991 ·The Lancet ·Simon M. Helfgott, Carles Lorenzo‐Bosquet, Raphael I. Kieval, David E. Trentham, (unknown), (unknown), Michael J. McKenna, Joseph B. Nadol	51
18	The effects of cyclosporin a on eicosanoid excretion in patients with rheumatoid arthritis 1991 ·Arthritis & Rheumatism ·M. Weinblatt, Simon M. Helfgott, Jonathan S. Coblyn, J Spragg, (unknown), (unknown), Agnes L. Maier, Waltraud M. Uedelhoven, Robin Lorenz, Christian Weber	6
19	Detection of arthritogenic factor in adjuvant arthritis. 1988 ·The Journal of Immunology ·Simon M. Helfgott, Raphael I. Kieval, F. C. Breedveld, Ernest Brahn, Chi Young, Roselynn Dynesius‐Trentham, David E. Trentham	12
20	An arthritogenic lymphokine in the rat. 1985 ·The Journal of Experimental Medicine ·Simon M. Helfgott, Roselynn Dynesius‐Trentham, Ernest Brahn, David E. Trentham	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact